| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/22/1995 | WO1995016460A1 Composition containing soluble thrombomodulins |
| 06/22/1995 | WO1995016459A1 Controlled superovulation method for female cattle undergoing prolonged anoestrus, anoestruation method and superovulation kit |
| 06/22/1995 | WO1995016458A1 Il-6 therapy |
| 06/22/1995 | WO1995016457A1 Aspartame for use as a therapeutically active substance |
| 06/22/1995 | WO1995016437A1 Method of transmitting a biologically active material to a cell |
| 06/22/1995 | WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 06/22/1995 | WO1995016430A2 Cosmetic and/or pharmaceutical preparations |
| 06/22/1995 | WO1995016353A1 Systemic gene treatment of connective tissue diseases |
| 06/22/1995 | WO1995016348A1 Method and apparatus for treating a body fluid |
| 06/22/1995 | WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/22/1995 | WO1995014780A3 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| 06/22/1995 | WO1995013380A3 Method and reagent for treatment of arthritic conditions |
| 06/22/1995 | WO1995011048A3 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO) |
| 06/22/1995 | WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 06/22/1995 | WO1995009611A3 Stable protein: phospholipid compositions and methods |
| 06/22/1995 | WO1995009241A3 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 06/22/1995 | WO1995007992A3 Cloned glutamic acid decarboxylase |
| 06/22/1995 | DE4342560A1 Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics |
| 06/22/1995 | DE4334936C1 Medicament for treating hypertension |
| 06/22/1995 | CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 06/22/1995 | CA2179149A1 Methods and materials for the detection of staphylococcus aureus |
| 06/22/1995 | CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 06/22/1995 | CA2179018A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
| 06/22/1995 | CA2178965A1 Origin of replication complex genes, proteins and methods |
| 06/22/1995 | CA2178954A1 Controlled superovulation method for female cattle undergoing prolonged anoestrus, anoestruation method and superovulation kit |
| 06/22/1995 | CA2178927A1 Peptide inhibitors of cxc intercrine molecules |
| 06/22/1995 | CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity |
| 06/22/1995 | CA2155929A1 Systemic gene treatment of connective tissue diseases |
| 06/22/1995 | CA2155844A1 Antiviral composition of viral protein trans-dominant variants |
| 06/22/1995 | CA2155568A1 Human interferon expression vectors for treating aids |
| 06/22/1995 | CA2154761A1 Method and apparatus for treating a body fluid |
| 06/21/1995 | EP0658624A2 Recombinant genes expressing pp14 |
| 06/21/1995 | EP0658585A2 Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants |
| 06/21/1995 | EP0658569A1 Method for decoloring human serum albumin |
| 06/21/1995 | EP0658568A1 Glucagon-like insulinotropic peptides, compositions and methods |
| 06/21/1995 | EP0658551A1 Cyclic depsipeptides having 18 ringatoms and their use in controlling endoparasites |
| 06/21/1995 | EP0658346A1 Use of hydrolytic enzymes for prophylaxis of abortion at pregnant women with idiopathic abortus habitualis in the anamnesis |
| 06/21/1995 | EP0658345A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 06/21/1995 | EP0658227A1 Paper strengthened with solubilized collagen, and method for making the same |
| 06/21/1995 | EP0658210A1 Translocation signal facilitated nuclear delivery of macromolecules |
| 06/21/1995 | EP0658206A1 Inhibitor resistant serine proteases |
| 06/21/1995 | EP0658205A1 Lipoprotein associated phospholipase a 2?, inhibitors thereof and use of the same in diagnosis and therapy |
| 06/21/1995 | EP0658204A1 DNA ENCODING THE HEME-REGULATED EUKARYOTIC INITIATION FACTOR 2$g(a) KINASE |
| 06/21/1995 | EP0658202A1 Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them |
| 06/21/1995 | EP0658200A1 Glucagon receptors |
| 06/21/1995 | EP0658199A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
| 06/21/1995 | EP0658198A1 Multicistronic expression units and their use |
| 06/21/1995 | EP0658197A1 Targeted replacement of a gene without endogenous and selectable residual sequences |
| 06/21/1995 | EP0658169A1 Diamino acid derivatives as antihypertensives |
| 06/21/1995 | EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 06/21/1995 | EP0658117A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 06/21/1995 | EP0658116A1 Methods useful in endotoxin prophylaxis and therapy |
| 06/21/1995 | EP0658115A1 Peptide medicaments for treating disease |
| 06/21/1995 | EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 06/21/1995 | EP0658112A1 A novel conjugate, its preparation and use and a substrate prepared with the conjugate |
| 06/21/1995 | EP0658111A1 Methods for enhancing drug delivery with modified saponins |
| 06/21/1995 | EP0658106A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass |
| 06/21/1995 | EP0658102A1 Novel pharmaceutical peptide preparations for general delivery |
| 06/21/1995 | EP0658099A1 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative. |
| 06/21/1995 | EP0658096A1 Stabilized chewable antimicrobial animal foodstuff |
| 06/21/1995 | EP0658082A1 Combination of germicidal agents |
| 06/21/1995 | EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 06/21/1995 | EP0540547B1 Prophylactic and therapeutic applications of peroxidases |
| 06/21/1995 | EP0511970B1 Method for preparing an enzymatic hydrolyzate |
| 06/21/1995 | EP0458959B1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
| 06/21/1995 | EP0411105B1 Bone collagen matrix for implants |
| 06/21/1995 | EP0393035B1 Method for the isolation of active enzyme(s) from krill tissue |
| 06/21/1995 | CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition |
| 06/20/1995 | US5426185 Antiarrhythmia agents having reduced side effects |
| 06/20/1995 | US5426181 DNA encoding cytokine-induced protein, TSG-14 |
| 06/20/1995 | US5426180 Methods of making single-stranded circular oligonucleotides |
| 06/20/1995 | US5426177 Ciliary neurotrophic factor receptor |
| 06/20/1995 | US5426103 Certain macrocyclic lactam derivatives |
| 06/20/1995 | US5426100 Therapeutic uses including antitumor agents, anticoagulants and wound healing agents |
| 06/20/1995 | US5426099 Process for inducing analgesia, peptides and therapeutic compositions |
| 06/20/1995 | US5426098 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
| 06/20/1995 | US5426097 Calreticulin: a novel antithrombotic agent |
| 06/20/1995 | US5426096 Use of human growth hormone |
| 06/20/1995 | US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor |
| 06/20/1995 | US5426046 Human monoclonal antibody to lipid A of gram negative bacteria |
| 06/20/1995 | US5426044 Minactivin compositions and antibodies to minactivin |
| 06/20/1995 | US5426038 Process for production of an antibiotic compound with Zalerion arboricola |
| 06/20/1995 | US5426031 Extraction methods for preparing thromboplastin reagents |
| 06/20/1995 | US5425943 Modified tPA-containing injection composition having increased solubility |
| 06/20/1995 | US5425942 Giant protein complex; useful in screening for cancer |
| 06/20/1995 | US5425940 Cancer treatment; synergistic mixture |
| 06/20/1995 | US5425937 Hair treatment composition and hair care product, both containing anti-keratin antibody, and production of anti-keratin antibody |
| 06/20/1995 | US5425936 Useful for therapeutic, prophylactic and diagnostic purposes |
| 06/20/1995 | CA1336034C Biodegradable polypeptide and the use thereof for the gradual release of drugs |
| 06/18/1995 | CA2138349A1 Method for decoloring human serum albumin |
| 06/16/1995 | CA2137897A1 Biaromatic compounds derived from amides; pharmaceutical and cosmetic compositions containing the same and their uses |
| 06/15/1995 | WO1995016209A1 Process for the production of combinatorial compound libraries |
| 06/15/1995 | WO1995016051A2 Methods and compositions for the suppression of neu mediated transformation |
| 06/15/1995 | WO1995016040A2 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
| 06/15/1995 | WO1995016038A2 Humanized antibodies and uses thereof |
| 06/15/1995 | WO1995016037A1 Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use |
| 06/15/1995 | WO1995016036A2 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
| 06/15/1995 | WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |